Literature DB >> 7566347

Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components.

S H Yen1, W K Liu, F L Hall, S D Yan, D Stern, D W Dickson.   

Abstract

Neurofibrillary lesions found in Alzheimer disease (AD) are known to react with antibodies raised against different molecules. At least 20 components have been detected in neurofibrillary tangles. These components can be roughly categorized into five groups, which include structural proteins, kinases and other cytosolic enzymes, stress-related molecules, amyloid and amyloid binding proteins, and others. Among them, an abnormal form of microtubule associated protein tau, PHF-tau, is a major component of Alzheimer NFT. Kinases associated with NFT, especially those belonging to the family of proline-directed Ser/Thr kinases, are considered to be important for PHF-tau hyperphosphorylation. A potentially significant kinase is a Cdc2-related kinase, which is associated tightly with paired helical filaments, has a molecular weight of 33kDa and is different from other known Cdc2-related kinases. The possibility that some of the NFT-associated elements may play an active role in the pathogenesis of Alzheimer's disease was supported by recent studies, in which advanced glycated products and markers of oxidant stress were located in NFT. In addition, PHF-tau was found to be glycated, and in vitro glycated tau was capable of inducing oxidant stress. Further characterization of different components of NFT by biochemical and other approaches will be important for understanding the mechanisms involved in the supramolecular aggregation of PHF within NFT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566347     DOI: 10.1016/0197-4580(95)00022-7

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Oxidative stress mediates tau-induced neurodegeneration in Drosophila.

Authors:  Dora Dias-Santagata; Tudor A Fulga; Atanu Duttaroy; Mel B Feany
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

Review 2.  Discovery of new lesions in neurodegenerative diseases with monoclonal antibody techniques: is there a non-amyloid precursor to senile plaques?

Authors:  D W Dickson
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

Review 3.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Grutzendler; J C Morris
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?

Authors:  Shi Du Yan; Angelika Bierhaus; Peter P Nawroth; David M Stern
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 6.  Oxidative stress in Alzheimer disease.

Authors:  Alejandro Gella; Nuria Durany
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

7.  Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology.

Authors:  Kooresh Shoghi-Jadid; Jorge R Barrio; Vladimir Kepe; Sung-Cheng Huang
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

8.  Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation.

Authors:  Yunpeng Huang; Zhihao Wu; Yu Cao; Minglin Lang; Bingwei Lu; Bing Zhou
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

9.  Novel approach for accurate tissue-based protein colocalization and proximity microscopy.

Authors:  Mirjam I Lutz; Carmen Schwaiger; Bernhard Hochreiter; Gabor G Kovacs; Johannes A Schmid
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.